Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Značilnosti raka požiralnika in raka želodca
Authors:ID Velenik, Vaneja (Author)
Files:.pdf PDF - Presentation file, download (506,26 KB)
MD5: EAE2A6B445B8FA7614C83D656454F84A
PID: 20.500.12556/dirros/8a5a0d6b-2a76-423b-936c-fc869e7da64c
 
Language:Slovenian
Typology:1.08 - Published Scientific Conference Contribution
Organization:Logo OI - Institute of Oncology
Abstract:Po podatkih Globocana je v letu 2008 za rakom zbolelo 12,7 milijona ljudi in umrlo zaradi njega 7,6 milijona ljudi (1). Kar 56 % novih primerov in 63 % smrti zaradi raka so zabeležili v manj razvitih področjih sveta. Najpogostejši so bili pljučni rak (1,61 milijona, 12,7 % vseh), rak dojke (1,38 milijona, 10,9 % vseh) ter rak debelega črevesa in danke (1,23 milijona, 9,7 % vseh). Najpogostejši vzrok smrti zaradi raka so bili pljučni rak (1,38 milijona, 18,2 % vseh), rak želodca (738 tisoč smrti, 9,7 % vseh) in rak jeter (696 tisoč smrti, 9,2 % vseh). Predvidevanja o bremenu raka so še bolj črnogleda. Leta 2030 naj bi za to boleznijo na novo zbolelo 20,3 milijona ljudi in umrlo zaradi raka 13,2 milijona ljudi. Incidenca naj bi se torej povečala za 75 %, v slabše razvitih deželah pa naj bi se skoraj podvojila v primerjavi z letom 2008. Rak bo glavni vzrok morbiditete in mortalitete v vsaki deželi sveta. Vsepovsod bomo opazovali porast deleža raka debelega črevesa in danke, raka dojk ter raka prostate, v najrazvitejših deželah tudi raka pljuč pri ženskah. Incidenca raka želodca in raka materničnega vratu bosta v upadanju, prav tako pa tudi rak pljuč pri moških v razvitih deželah (2).
Keywords:rak požiralnika, rak želodca, značilnosti
Year of publishing:2014
Publication status in journal:Published
Article version:Publisher's version of article
Number of pages:str. 19-22, 73
Numbering:Letn. 18, št. 1
PID:20.500.12556/DiRROS-8626 New window
UDC:616.3-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-9NWS88NG
COBISS.SI-ID:1807483 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:2553
Downloads:649
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Share:AddThis
AddThis uses cookies that require your consent. Edit consent...

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Šola: tumorji prebavil II, Ljubljana, 15. 11. 2013
Publisher:Onkološki inštitut
COBISS.SI-ID:1807227 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:English
Title:[Characteristics of oesophageal and gastric cancers]
Abstract:According to the Globocan data, a total of 12.7 million people were diagnosed with cancer and 7.6 million people died of this disease in 2008. As many as 56% of new cancer cases and 63% of cancer deaths were recorded in less developed regions of the world. The most common cancers were lung cancer (1.61 million; 12.7% of all cases), breast cancer (1.38 million, 10.9% of all cases) and colorectal cancer (1.23 million, 9.7% of all cases). The leading causes of cancer-related death were lung cancer (1.38 million, 18.2% of all cancer deaths), gastric cancer (738 thousand, 9.7% of all cancer deaths) and liver cancer (696 thousand, 9.2% of all cancer deaths). Projections of the cancer burden are even grimmer. In 2030, a total of 20.3 million people will be newly diagnosed with cancer, and 13.2 million people will die from this disease. The incidence is thus said to increase by 75% and to almost double in less developed countries compared to 2008. Cancer will become the leading cause of morbidity in every country of the world. Everywhere, we will witness an increase in the share of colorectal cancer, breast cancer and prostate cancer, while the most developed countries will also note an increase in lung cancer in women. The incidence of gastric and cervical cancers will drop, as will the incidence of lung cancer in men in the developed countries (2).


Archive

niGradiv

Back